Id |
Subject |
Object |
Predicate |
Lexical cue |
T60 |
0-25 |
Sentence |
denotes |
2 Results and discussion |
T61 |
27-72 |
Sentence |
denotes |
2.1 Rational design of bisubstrate compounds |
T62 |
73-327 |
Sentence |
denotes |
In order to mimic the transition state of the cap RNA 2′-O-methylation, the design of the SAM mimetics relies on the coupling of the adenosine moiety of the SAM cofactor to another adenosine modified at 2′-O-position with an ethyl group to form the link. |
T63 |
328-439 |
Sentence |
denotes |
Thus, we first synthesized the dinucleoside 1 with a 2′-O-ethyl amino link between both adenosines (Scheme 2 ). |
T64 |
440-651 |
Sentence |
denotes |
The major advantage of this N-containing linker is the possibility to functionalize the secondary amine with a large variety of groups which may lead to additional binding with specific sites of RNA 2′-O-MTases. |
T65 |
652-876 |
Sentence |
denotes |
According to the schematic representation of the transition state of the 2′-O-methylation (Scheme 1), an accurate mimic was represented by compound 2 with the α-amino acid chain of the SAM branched to the nitrogen atom [16]. |
T66 |
877-1005 |
Sentence |
denotes |
We further modified this side chain under α-amino-ester form or α-amino-amide form to result in compounds 3 and 4, respectively. |
T67 |
1006-1133 |
Sentence |
denotes |
Then instead of polar modifications, we introduced hydrophobic substituents on the secondary amine in dinucleosides 5, 6 and 7. |
T68 |
1134-1265 |
Sentence |
denotes |
Finally we chose to obtain compound 9 with a nitrobenzenesulfonamide moiety as a structural particular element of the dinucleoside. |
T69 |
1266-1428 |
Sentence |
denotes |
Indeed, as a global observation in medicinal chemistry the N-arylsulfonamide motif is regularly found in antitumor agents as in some antiviral inhibitors [19,20]. |
T70 |
1429-1652 |
Sentence |
denotes |
Further, we explored the combination of the nitro group with another substituent (MeO, CF3, Cl) at diverse positions in the phenyl ring resulting in the compounds 10–13 and we also removed the nitro group in 14 (Scheme 3 ). |
T71 |
1653-1869 |
Sentence |
denotes |
In addition, we chose to replace the sulfone by a methylene group in 15–16 (Scheme 4 ) to assess the sulfone contribution to the inhibitory activity obtained with dinucleosides containing the N-arylsulfonamide motif. |
T72 |
1870-2656 |
Sentence |
denotes |
Scheme 2 Synthesis of dinucleosides 1–9. (a) K2CO3, KI, DMF, 50 °C, 24 h, 74%; (b) PhSH, K2CO3, DMF, 25 °C, 2 h, 76%; (c) TFA/H2O 8/2, 25 °C, 3 h, 76% for 1 and 34% for 9; (d) (i) 21, AcOH, CH2Cl2, 25 °C, 2 h, (ii) NaBH(OAc)3, 25 °C, 2 h, 93%; (e) (i) TFA/H2O 8/2, 25 °C, 3 h, (ii) 2 M aqueous solution LiOH, 25 °C, 0.5 h, 32%; (f) TFA/H2O 8/2, 25 °C, 3 h, 35%; (g) (i) TFA/H2O 8/2, 25 °C, 3 h, (ii) 7 M NH3/MeOH, 30 °C, 24 h, 38%; (h) 1-bromobutane, DIEA, NMP, microwave 110 °C, 4 h, 47% for 23; 1-bromo-3-phenylpropane, DIEA, NMP, microwave 110 °C, 4 h, 53% for 24, methyl 4-bromobutyrate, DIEA, NMP, microwave 110 °C, 3.5 h, 58% for 25; (i) (i) TFA/H2O 8/2, 25 °C, 6 h, 72% for 5; 3 h, 28% for 6; 5.5 h, 60% for 7; 5.5 h for 8. (ii) 2 M aqueous solution LiOH, 0 °C, 0.5 h, 36% for 8. |
T73 |
2657-2829 |
Sentence |
denotes |
Scheme 3 Synthesis of dinucleosides 10–13. (a) Ns-Cl, NEt3, DMF, 25 °C, 3.5 h, 40–72%; (b) 17, KI, K2CO3, DMF, 50 °C, 24 h, 43–52%; (c) TFA/H2O 8/2, 25 °C, 3 h–5 h, 13–20%. |
T74 |
2830-3205 |
Sentence |
denotes |
Scheme 4 Synthesis of dinucleosides 14–16. (a) 4-chlorobenzenesulfonyl chloride, NEt3, CH2Cl2, 0 °C, 3 h, 90%. (b) (i) 4-chloro-3-nitrobenzaldehyde, AcOH, DCE, 40 °C, 20 min; (ii) NaBH(OAc)3, 40 °C, 16 h, 87%. (c) (i) 4-chlorobenzaldehyde, AcOH, DCE, 40 °C, 20 min. (ii) NaBH(OAc)3, 40 °C, 16 h, 72%. (d) TFA/H2O 8/2, 25 °C, 3 h, 48% for 14; 6 h, 25% for 15; 6 h, 37% for 16. |
T75 |
3207-3221 |
Sentence |
denotes |
2.2 Chemistry |
T76 |
3222-3462 |
Sentence |
denotes |
The retrosynthetic analysis of the dinucleoside 1 structure suggested the coupling reaction between the tosyl derivative 17 previously described by us (Scheme 2) [14], and the readily accessible 5′-amino-2′,3′-isopropylidene adenosine [21]. |
T77 |
3463-3678 |
Sentence |
denotes |
The direct N-alkylation at room temperature did not afford the secondary amine in satisfactory yields and when increasing the temperature to enhance the reactivity of the primary amine, we noticed degradation of 17. |
T78 |
3679-3875 |
Sentence |
denotes |
To circumvent the lack of reactivity of primary amines, a synthetic method using nitrobenzenesulfonamides (Ns-amides) as both a protecting and activating group has been developed by Fukuyama [22]. |
T79 |
3876-3989 |
Sentence |
denotes |
The main advantage of this nosyl strategy is that both alkylation and deprotection proceed under mild conditions. |
T80 |
3990-4175 |
Sentence |
denotes |
Recently, the 2-nitrobenzenesulfonamide has been used successfully to synthetize transition state analogs of DNA methylation based on the coupling of cytosine analogs to adenosine [15]. |
T81 |
4176-4300 |
Sentence |
denotes |
In the same way, we envisaged the coupling between 17 and the 5′-nosyl adenosine 18 to obtain the dinucleoside 1 (Scheme 2). |
T82 |
4301-4570 |
Sentence |
denotes |
The building block 18 was prepared in 74% yield by reacting 4-nitrobenzenesulfonyl chloride [22] that has a similar reactivity to 2-nitrobenzenesulfonyl chloride as used in Ref. [15], with 5′-amino-2′,3′-isopropylidene adenosine prepared upon published procedures [23]. |
T83 |
4571-4729 |
Sentence |
denotes |
N-alkylation of Ns-amide 18 with 17 in the presence of K2CO3 in DMF at room temperature did not afford the expected dinucleoside 19, even at high temperature. |
T84 |
4730-4882 |
Sentence |
denotes |
Nevertheless, according to the literature [24], the addition of a catalytic amount of KI to the reaction mixture was beneficial to give 19 in 74% yield. |
T85 |
4883-5005 |
Sentence |
denotes |
Facile deprotection of 19 by treatment with a nucleophilic thiolate produced the desired secondary amine 20 in high yield. |
T86 |
5006-5116 |
Sentence |
denotes |
Removal of sugar protecting groups has been accomplished in acidic medium to give dinucleoside 1 in 76% yield. |
T87 |
5117-5282 |
Sentence |
denotes |
Likewise, the acidic treatment was applied to the intermediate Ns-amide 19 to afford the 4-nitrobenzenesulfonamide-containing dinucleoside 9 in 34% yield (Scheme 2). |
T88 |
5283-5473 |
Sentence |
denotes |
Compounds 2, 3 and 4 were obtained from key compound 20 via reductive amination of the aldehyde 21 that was prepared in three steps from l-aspartic acid following a published procedure [25]. |
T89 |
5474-5577 |
Sentence |
denotes |
Reductive amination was conducted in the presence of sodium triacetoxyborohydride and acetic acid [26]. |
T90 |
5578-5657 |
Sentence |
denotes |
The resulting fully protected dinucleoside 22 was isolated in high yield (93%). |
T91 |
5658-5763 |
Sentence |
denotes |
Then, sugar hydroxyls and amine were deprotected by TFA treatment and afforded methyl ester derivative 3. |
T92 |
5764-5926 |
Sentence |
denotes |
Subsequent basic treatment with LiOH converted the methyl ester in carboxylic acid and dinucleoside 2 with α-amino acid chain similar to that of SAM was obtained. |
T93 |
5927-6110 |
Sentence |
denotes |
Finally, the SAM analogue 4 with an amide function instead of a carboxylic acid in α-amino acid chain was prepared from 22 upon a final treatment with 7 M methanolic ammonia solution. |
T94 |
6111-6368 |
Sentence |
denotes |
Dinucleosides 5, 6 and 7 were rather synthesized through N-alkylation of 20 with 1-bromobutane, 1-bromo-3-phenylpropane or methyl-4-bromobutyrate, respectively, in N-methylmorpholine in the presence of diisopropylethylamine (DIEA) at 110 °C under microwave. |
T95 |
6369-6480 |
Sentence |
denotes |
These specific conditions were optimized for a successful synthesis of 23, 24 and 25 with an average 50% yield. |
T96 |
6481-6592 |
Sentence |
denotes |
This moderate yield results from double N-alkylations (observed in mass spectrometry) and incomplete reactions. |
T97 |
6593-6678 |
Sentence |
denotes |
Increasing temperature of the reactions neither did drive the reaction to completion. |
T98 |
6679-6790 |
Sentence |
denotes |
Next, 23, 24 and 25 were deprotected upon TFA treatment to obtain N-alkyl derivatives 5, 6 and 7, respectively. |
T99 |
6791-6958 |
Sentence |
denotes |
Subsequently, an additional basic treatment with 2 M LiOH was applied to 7 to convert the methyl ester moiety into the carboxylic acid-ended alkyl chain of compound 8. |
T100 |
6959-7159 |
Sentence |
denotes |
The same synthetic route used for the preparation of nosyl-containing dinucleoside 9 was followed to synthesize compounds 10–13 with diverse Ns-amide moieties as analogs of the nosyl group (Scheme 3). |
T101 |
7160-7429 |
Sentence |
denotes |
The reaction of 5′-amino-2′,3′-isopropylidene adenosine [23] with four diversely substituted (OMe, CF3, Cl) and commercially available nitrobenzenesulfonyl chloride reagents afforded the corresponding N-nosyl adenosines 26–29 with 40–72% yield [[27], [28], [29], [30]]. |
T102 |
7430-7573 |
Sentence |
denotes |
Their subsequent coupling with 17 in the presence of K2CO3 and KI gave the corresponding dinucleosides 30–33 in moderate yields from 43 to 52%. |
T103 |
7574-7724 |
Sentence |
denotes |
A final TFA treatment provided the respective N-nosyl adenine dinucleosides 10–13 which were purified by reversed-phase chromatography (Yield 13–20%). |
T104 |
7725-7850 |
Sentence |
denotes |
Scheme 4 depicts the synthesis of the adenine dinucleosides 14–16 from the intermediate NH-linked dinucleoside 20 (Scheme 2). |
T105 |
7851-7979 |
Sentence |
denotes |
The reaction of 4-chlorobenzenesulfonyl chloride with 20 in the presence of NEt3 [31,32] followed by a TFA treatment yielded 14. |
T106 |
7980-8208 |
Sentence |
denotes |
The treatment of 20 with 4-chloro-3-nitrobenzaldehyde or 4-chlorobenzaldehyde and sodium triacetoxyborohydride, followed by the removal of protective groups in acidic conditions resulted in dinucleosides 15 and 16, respectively. |
T107 |
8209-8325 |
Sentence |
denotes |
It is noteworthy that this reductive amination conducted at 40 °C increased the yields to 71% and 81%, respectively. |
T108 |
8327-8369 |
Sentence |
denotes |
2.3 RNA methyltransferase activity assays |
T109 |
8370-8467 |
Sentence |
denotes |
Compounds 1–16 were tested for their ability to inhibit the methylation of the RNA cap structure. |
T110 |
8468-8744 |
Sentence |
denotes |
The inhibition induced by each compound (50 μM) was determined by a radioactive MTase assay (filter binding assay) which consists in measuring the [3H] radiolabeled methyl transferred from the methyl donor SAM onto RNA substrate (GpppAC4) synthetized by using T7 primase [33]. |
T111 |
8745-8965 |
Sentence |
denotes |
Compounds 1–16 designed as mimics of the transition state of RNA 2′-O-methylation were screened against several viral RNA 2′-O-MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West-Nile, Dengue, Vaccinia (VP39) viruses. |
T112 |
8966-9166 |
Sentence |
denotes |
At the same time, the compounds were tested against human RNA N7-MTase (hRNMT) and selected viral N7-MTases such as SARS-CoV nsp14 and Vaccinia D1-D12 complex to evaluate their specificity (Table 1 ). |
T113 |
9167-9264 |
Sentence |
denotes |
Table 1 Screening for inhibitory activity of sinefungin and compounds 1–16 at 50 μM on N7-MTases. |
T114 |
9265-9313 |
Sentence |
denotes |
Compounds Percentage of inhibition at 50 μM (%)a |
T115 |
9314-9355 |
Sentence |
denotes |
SARS-CoV nsp14 Vaccinia virusD1-D12 hRNMT |
T116 |
9356-9399 |
Sentence |
denotes |
Sinefungin 98.3 ± 0.2 99.8 ± 0.1 99.8 ± 0.2 |
T117 |
9400-9434 |
Sentence |
denotes |
1 31.0 ± 6.8 20.3 ± 0.8 35.2 ± 4.9 |
T118 |
9435-9469 |
Sentence |
denotes |
2 72.0 ± 1.2 85.8 ± 2.5 77.4 ± 1.2 |
T119 |
9470-9504 |
Sentence |
denotes |
3 30.6 ± 9.3 32.1 ± 2.4 33.2 ± 4.3 |
T120 |
9505-9540 |
Sentence |
denotes |
4 13.1 ± 13.3 53.2 ± 2.6 12.2 ± 2.1 |
T121 |
9541-9561 |
Sentence |
denotes |
5 n.i n.i 27.5 ± 6.6 |
T122 |
9562-9597 |
Sentence |
denotes |
6 38.4 ± 11.7 11.6 ± 7.1 23.1 ± 9.7 |
T123 |
9598-9626 |
Sentence |
denotes |
7 n.i 69.2 ± 1.9 32.8 ± 16.1 |
T124 |
9627-9647 |
Sentence |
denotes |
8 43.0 ± 4.0 n.i n.i |
T125 |
9648-9682 |
Sentence |
denotes |
9 88.6 ± 1.3 49.8 ± 3.2 66.0 ± 6.1 |
T126 |
9683-9717 |
Sentence |
denotes |
10 96.6 ± 0.9 4.6 ± 0.3 31.8 ± 3.3 |
T127 |
9718-9752 |
Sentence |
denotes |
11 47.6 ± 2.8 5.3 ± 4.3 44.2 ± 8.5 |
T128 |
9753-9788 |
Sentence |
denotes |
12 94.6 ± 1.1 10.1 ± 5.5 23.3 ± 3.6 |
T129 |
9789-9823 |
Sentence |
denotes |
13 97.2 ± 2.7 2.8 ± 0.8 33.9 ± 3.3 |
T130 |
9824-9859 |
Sentence |
denotes |
14 96.2 ± 1.5 19.7 ± 3.8 20.2 ± 9.4 |
T131 |
9860-9887 |
Sentence |
denotes |
15 94.0 ± 1.1 4.3 ± 3.9 n.i |
T132 |
9888-9923 |
Sentence |
denotes |
16 75.9 ± 2.5 4.5 ± 15.1 14.7 ± 1.3 |
T133 |
9924-9978 |
Sentence |
denotes |
aValues are the mean of three independent experiments. |
T134 |
9979-10040 |
Sentence |
denotes |
The MTase activity was measured using a filter binding assay. |
T135 |
10041-10232 |
Sentence |
denotes |
Assays were carried out in reaction mixture [40 mM Tris-HCl (pH 8.0), 1 mM DTT, 1 mM MgCl2, 2 μM SAM and 0.1 μM 3H-SAM] in the presence of 0.7 μM GpppAC4 synthetic RNA and incubated at 30 °C. |
T136 |
10233-10339 |
Sentence |
denotes |
SARS-CoV nsp14 (50 nM), vaccinia virus capping enzyme (D1-D12) (41 U), human RNA N7 MTase (hRNMT) (50 nM). |
T137 |
10340-10427 |
Sentence |
denotes |
Compounds were previously dissolved in 100% DMSO. n.i: no inhibition detected at 50 μM. |
T138 |
10428-10555 |
Sentence |
denotes |
Unexpectedly, all the bisubstrate compounds were barely active against the 2′-O MTases of flaviviruses or coronavirus SARS-CoV. |
T139 |
10556-10625 |
Sentence |
denotes |
In contrast, most of the compounds displayed inhibition of N7-MTases. |
T140 |
10626-10805 |
Sentence |
denotes |
Dinucleoside 2 bearing the amino acid chain of the SAM showed some significant inhibition of both viral N7-MTases with a better activity on Vaccinia D1-D12 than on SARS-CoV nsp14. |
T141 |
10806-10973 |
Sentence |
denotes |
However, compound 2 also displayed a potent inhibition of hRNMT in the same range as the viral MTases displaying a lack of specificity against human and viral enzymes. |
T142 |
10974-11115 |
Sentence |
denotes |
The amino acid group of 2 seems essential for inhibition since compound 1 with a non-substituted NH linker weakly inhibited the three MTases. |
T143 |
11116-11252 |
Sentence |
denotes |
The replacement of the amino acid group with an α-amino-ester at the extremity in compound 3 is detrimental for the inhibitory activity. |
T144 |
11253-11440 |
Sentence |
denotes |
Interestingly, the dinucleoside 4 bearing an α-amino-amide specifically inhibited the viral protein Vaccinia D1-D12 complex whereas did not show any inhibition of SARS-CoV nsp14 or hRNMT. |
T145 |
11441-11652 |
Sentence |
denotes |
Replacing the amino acid chain by a more hydrophobic butyl or phenylpropyl chain in dinucleosides 5 and 6, respectively, we aimed at favoring the Van der Waals interactions in hydrophobic pockets of the protein. |
T146 |
11653-11729 |
Sentence |
denotes |
Only compound 6 showed a moderate but specific inhibition of SARS-CoV nsp14. |
T147 |
11730-11987 |
Sentence |
denotes |
The removal of the NH2 of the amino acid chain of the broader spectrum inhibitor 2 with an ester-ended butyl chain in compound 7 or with an acid-ended butyl chain in 8 induced weaker but more specific inhibitions of Vaccinia D1-D12 MTase and SARS-CoV nsp14. |
T148 |
11988-12092 |
Sentence |
denotes |
In the synthetic pathway of dinucleoside 1, the intermediate 19 bearing a 4-Ns-amide group was prepared. |
T149 |
12093-12277 |
Sentence |
denotes |
In view of the valuable properties of such motif in some antiviral or anticancer drugs [19,20] it seemed interesting to us to obtain dinucleoside 9 by simple acidic deprotection of 19. |
T150 |
12278-12454 |
Sentence |
denotes |
Of special interest, compound 9 showed a good and specific inhibition on SARS-CoV nsp14 confirming that the nosyl group contributes to the inhibitory activity with specificity. |
T151 |
12455-12713 |
Sentence |
denotes |
Then, we modulated the initial nosyl moiety with the nitro group in “para” position by introducing diverse hydrophobic substituents (Cl, OMe, CF3) at different positions on the phenyl ring and/or by varying the position of the nitro group in compounds 10–13. |
T152 |
12714-12799 |
Sentence |
denotes |
The addition of such substituents aimed at increasing the interactions with proteins. |
T153 |
12800-12893 |
Sentence |
denotes |
Like 9, the four dinucleosides 10–13 maintained a high inhibitory activity on SARS-CoV nsp14. |
T154 |
12894-13095 |
Sentence |
denotes |
The role of the nitro group on the phenyl ring was demonstrated by removing it in dinucleoside 14 bearing solely one chlorine atom in “para” position, thus the inhibitory effect was slightly decreased. |
T155 |
13096-13173 |
Sentence |
denotes |
These data indicated the importance of the hydrophobic Cl in “para” position. |
T156 |
13174-13430 |
Sentence |
denotes |
Finally, the resulting decreased inhibition when the sulfone moiety of 14 was replaced by a methylene group in compounds 15 and 16 stressed the importance of the N-arylsulfonylbenzene motif in the dinucleoside structure to maintain an effective inhibition. |
T157 |
13432-13513 |
Sentence |
denotes |
2.4 Dose-response testing of selected compounds against SARS-CoV nsp14 and hRNMT |
T158 |
13514-13711 |
Sentence |
denotes |
To confirm the observed inhibition of some adenine dinucleosides against SARS-CoV nsp14 N7-MTase, we further tested 10 compounds in a dose-response assay (Table 2 , Supporting Information Fig. S2). |
T159 |
13712-13835 |
Sentence |
denotes |
The selection of these compounds was based on their percentage inhibition higher than 50% against SARS-CoV nsp14 (Table 1). |
T160 |
13836-13945 |
Sentence |
denotes |
After pre-incubation with increasing concentrations of dinucleosides, the MTase activity was measured by FBA. |
T161 |
13946-14140 |
Sentence |
denotes |
The IC50 of compounds, deduced from Hill slope equation (Y = 100/(1+((X/IC50)^Hillslope) curve-fitting, ranged from 0.6 μM to 70.4 μM on SARS-CoV nsp14 and 10.9 μM to > 500 μM on hRNMT activity. |
T162 |
14141-14395 |
Sentence |
denotes |
Among all the potential inhibitors, three compounds 2, 6 and 11 showed the lowest inhibitory activity on SARS-CoV nsp14 with IC50 > 40 μM, the others have IC50 values in the micromolar range except 13 that showed an IC50 value in the submicromolar range. |
T163 |
14396-14513 |
Sentence |
denotes |
The potency of the derivative 13 to inhibit SARS-CoV nsp14 was comparable to the broad spectrum inhibitor sinefungin. |
T164 |
14514-14718 |
Sentence |
denotes |
However, it is noteworthy that compound 13 specifically inhibits the N7-MTase of SARS-CoV with a high 413-fold of specificity in dose-response testing whereas sinefungin is also active against hRNMT [11]. |
T165 |
14719-15019 |
Sentence |
denotes |
Remarkably 13 bearing a chlorine atom in “para” position and a nitro group in “meta” position displayed the best inhibition which was 6.5–9.5 fold more potent than the derivatives 10 and 12, respectively that contain the nitro in “ortho” position and a lipophilic group CF3 or MeO in “para” position. |
T166 |
15020-15179 |
Sentence |
denotes |
The comparison of IC50 values of 14 and 13 indicates that the addition of a nitro group in the phenyl ring increased the inhibitory activity by 2.5 fold in 13. |
T167 |
15180-15344 |
Sentence |
denotes |
These results confirm that the chlorine atom in “para” position and the presence of a nitro group seem crucial for submicromolar SARS-CoV nsp14 inhibitory activity. |
T168 |
15345-15451 |
Sentence |
denotes |
Table 2 Comparison of IC50 values of 10 most active compounds on SARS-CoV nsp14 and human RNMT activities. |
T169 |
15452-15502 |
Sentence |
denotes |
Compounds SARS-CoV nsp14 IC50a (μM) hRNMTIC50 (μM) |
T170 |
15503-15525 |
Sentence |
denotes |
Sinefunginb 0.36 <0.05 |
T171 |
15526-15549 |
Sentence |
denotes |
2 40.6 ± 3.2 10.9 ± 1.0 |
T172 |
15550-15567 |
Sentence |
denotes |
6 55.5 ± 5.1 >500 |
T173 |
15568-15584 |
Sentence |
denotes |
9 2.6 ± 0.2 >500 |
T174 |
15585-15602 |
Sentence |
denotes |
10 3.9 ± 0.4 >500 |
T175 |
15603-15629 |
Sentence |
denotes |
11 70.4 ± 4.9 169.3 ± 30.4 |
T176 |
15630-15655 |
Sentence |
denotes |
12 5.7 ± 0.5 275.9 ± 28.7 |
T177 |
15656-15681 |
Sentence |
denotes |
13 0.6 ± 0.1 247.5 ± 14.9 |
T178 |
15682-15698 |
Sentence |
denotes |
14 1.5 ± 0.1 n.d |
T179 |
15699-15715 |
Sentence |
denotes |
15 2.4 ± 0.2 n.i |
T180 |
15716-15732 |
Sentence |
denotes |
16 9.9 ± 0.9 n.d |
T181 |
15733-15829 |
Sentence |
denotes |
a Concentration inhibiting MTase activity by 50%; mean value from three independent experiments. |
T182 |
15830-15864 |
Sentence |
denotes |
b values from the literature [11]. |
T183 |
15865-16070 |
Sentence |
denotes |
The MTase activity for IC50 determinations was measured using a filter binding assay as described above. n.i: no inhibition detected at 50 μM; n.d: not determined due to inhibition lower than 50% at 50 μM. |
T184 |
16072-16120 |
Sentence |
denotes |
2.5 Thermal shift DSF assays for SARS-CoV nsp14 |
T185 |
16121-16321 |
Sentence |
denotes |
SARS-CoV nsp14-inhibitor interactions were further investigated by monitoring the thermal stability of the protein using differential scanning fluorimetry (DSF) (Supporting Information, Fig. S3) [34]. |
T186 |
16322-16534 |
Sentence |
denotes |
The change in thermal stability of SARS-CoV nsp14 was monitored in response to binding of the natural cofactor substrate SAM, sinefungin and the 9 most active and specific compounds 6 and 9–16 with IC50 < 100 μM. |
T187 |
16535-16744 |
Sentence |
denotes |
As expected, SARS-CoV nsp14 displayed an increased melting temperature (T m) value with SAM (+6.5 °C) and sinefungin (+4.4 °C) whose structure only differs by a C–NH2 in place of S+-CH3 group in SAM (Fig. 2 ). |
T188 |
16745-16960 |
Sentence |
denotes |
The binding experiments with the bisubstrate inhibitors showed that all dinucleosides stabilized the SARS-CoV nsp14 protein (T m > 40 °C) with a T m shift from +4.6 °C to +10.8 °C (Supporting Information, Table S1). |
T189 |
16961-17095 |
Sentence |
denotes |
Eight of the 9 examined compounds increased the stability of SARS-CoV nsp14 more efficiently than the well-known inhibitor sinefungin. |
T190 |
17096-17298 |
Sentence |
denotes |
More interestingly, T m values for SARS-CoV nsp14 were larger in the presence of five compounds 10 and 12–15 than with the natural enzyme substrate SAM, suggesting strong protein-inhibitor interactions. |
T191 |
17299-17620 |
Sentence |
denotes |
Remarkably, the highest T m was observed with the most efficient inhibitor 13 (IC50 0.6 ± 0.1 μM) that stabilizes SARS-CoV nsp14 against thermal denaturation with a ΔT m +10.8 °C and exhibits notable binding affinity (apparent KD 1.3 ± 0.87 μM), as deduced from TSA performed with increasing concentration of compound 13. |
T192 |
17621-17717 |
Sentence |
denotes |
This demonstrates a favorable interaction and highlights the inhibitor potential of compound 13. |
T193 |
17718-17923 |
Sentence |
denotes |
The T m comparison of compounds 16, 15 and 13 showed a respective increase in SARS-CoV nsp14 stability, settling the importance of the sulfone group, the Cl and NO2 substituents in protein binding with 13. |
T194 |
17924-18034 |
Sentence |
denotes |
Thus the N-(4-Cl-3-NO2-phenylsulfonamide) moiety is notably preferred for optimal SARS-CoV nsp14 interactions. |
T195 |
18035-18240 |
Sentence |
denotes |
Another highlight is the thermal shift (+5.4 °C) for SARS-CoV nsp14 observed in the presence of compound 10 compared to 11, both only differ by the position of OCH3 and NO2 substituents in the phenyl ring. |
T196 |
18241-18367 |
Sentence |
denotes |
A higher stability and inhibition of SARS-CoV nsp14 was observed when the OCH3 group is in “para” position in dinucleoside 10. |
T197 |
18368-18501 |
Sentence |
denotes |
Fig. 2 Thermal shifts (ΔTm) of SARS-CoV nsp14 in the absence or presence of SAM, sinefungin and 9 dinucleoside inhibitors 6 and 9–16. |
T198 |
18502-18609 |
Sentence |
denotes |
Thermal stability of SARS-CoV nsp14 upon ligand binding was monitored by differential scanning fluorimetry. |
T199 |
18610-18810 |
Sentence |
denotes |
Assays were carried out in reaction mixture [20 mM HEPES (pH 7.5), 150 mM NaCl, 1x SYPRO orange dye] in the presence of 5 μM SARS-CoV nsp14 protein and 1 mM compound previously dissolved in 100% DMSO. |
T200 |
18811-18932 |
Sentence |
denotes |
The bars and error bars correspond to the mean values from three independent measurements and their s.d.’s, respectively. |
T201 |
18934-19014 |
Sentence |
denotes |
2.6 Molecular docking studies of SARS-CoV nsp14 in complex with dinucleoside 13 |
T202 |
19015-19185 |
Sentence |
denotes |
To address the molecular bases of N7-MTase nsp14 inhibition by the dinucleosides, we performed computational docking studies of the best inhibitor 13 using Autodock Vina. |
T203 |
19186-19285 |
Sentence |
denotes |
The docking was based on the SARS-CoV nsp14-nsp10 complex structure solved in presence of SAM [35]. |
T204 |
19286-19505 |
Sentence |
denotes |
SARS-CoV nsp14 is a bifunctional enzyme carrying RNA cap guanine N7-MTase at the C-terminal domain for mRNA capping (which is not influenced by nsp10) and 3′-5′-exoribonuclease at the N-terminal domain for proofreading. |
T205 |
19506-19679 |
Sentence |
denotes |
The N7-MTase domain exhibits an original fold and the methyl receptor cap RNA (GpppA-RNA) and SAM bind in proximity in a highly constricted pocket to achieve methyltransfer. |
T206 |
19680-19774 |
Sentence |
denotes |
The compound 13 was modeled in the SAM binding pocket of the SARS-CoV nsp14 structure (PDB ID: |
T207 |
19775-19794 |
Sentence |
denotes |
5C8T [35] & PDB ID: |
T208 |
19795-19806 |
Sentence |
denotes |
5NFY [36]). |
T209 |
19807-19950 |
Sentence |
denotes |
At first sight, the overlay of the N-adenosine of 13 with the adenosine of SAM bounded structure is suitable (Supporting Information, Fig. S4). |
T210 |
19951-20162 |
Sentence |
denotes |
More interestingly, the nitrobenzenesulfonamide core of 13 binds into a SARS-CoV nsp14 well known binding site formed by Trp385, Phe401, Tyr420, Phe426 and Phe506 (Fig. 3 , Supporting Information, Fig. S5) [35]. |
T211 |
20163-20263 |
Sentence |
denotes |
Naturally, the side chains of these amino acids enclose the nucleobase guanine of the cap structure. |
T212 |
20264-20412 |
Sentence |
denotes |
In this cap-binding site, Phe426 was shown to have the largest influence on the N7-MTase activity, and F426A mutation reduced MTase activity by 50%. |
T213 |
20413-20551 |
Sentence |
denotes |
With 13, the orientation of the Phe426 residue all around the nitrobenzenesulfonamide leads to the formation of π-π stacking interactions. |
T214 |
20552-20685 |
Sentence |
denotes |
In addition, there are other hydrophobic interactions between the phenylsulfonamide moiety and aromatic residues of the binding site. |
T215 |
20686-20810 |
Sentence |
denotes |
All these interactions may explain the strong inhibition observed with phenyl-containing compounds, notably compounds 13–15. |
T216 |
20811-20976 |
Sentence |
denotes |
Moreover, Asn386 is located in proximity to the methylation site and forms two hydrogen bonds with the guanine moiety favoring its right orientation for methylation. |
T217 |
20977-21098 |
Sentence |
denotes |
Here, fixed on the nitrobenzenesulfonamide core of 13, the chlorine atom forms a halogen bond with Asn386 (Fig. 4 ) [37]. |
T218 |
21099-21301 |
Sentence |
denotes |
The formation of a double hydrogen bond interaction was observed between the nitro group and Arg310 that normally interacts with the second phosphate group of the triphosphate bond in the cap structure. |
T219 |
21302-21452 |
Sentence |
denotes |
The docking also suggests that the sulfone group of 13 avoids flexibility of the N-nosyl substituent, thus increasing its orientation into the pocket. |
T220 |
21453-21627 |
Sentence |
denotes |
This constraint may explain the difference in activity (IC50) and stabilizing effect (T m) between compounds 13 and 15 that contains a methylene group instead of the sulfone. |
T221 |
21628-21737 |
Sentence |
denotes |
Finally, the common element of all dinucleosides is an adenosine linked to a N-adenosine by the 2′O position. |
T222 |
21738-21923 |
Sentence |
denotes |
Its contribution is well defined by the formation of intermolecular hydrogen bonds between the adenosine and Gly333 (3′OH), Ile338 (5′OH), Lys336 (N7) and His424 (N1) residues (Fig. 4). |
T223 |
21924-22053 |
Sentence |
denotes |
All the major interactions maintain 13 in a suitable orientation in the binding site in place of the natural substrate GpppA-RNA. |
T224 |
22054-22210 |
Sentence |
denotes |
The docking model of 13 is consistent with our inhibition experimental data and high thermal stability of SARS-CoV nsp14 in the presence of these compounds. |
T225 |
22211-22287 |
Sentence |
denotes |
Fig. 3 Modeling results in the SAM binding pocket of SARS-CoV nsp14 (PDB ID: |
T226 |
22288-22357 |
Sentence |
denotes |
5C8T, resolution 3.2 Å). (A) Amino acids surrounding dinucleoside 13. |
T227 |
22358-22465 |
Sentence |
denotes |
Hydrogen and halogen bonds are indicated by red dashes. π-π stacking interaction is indicated by red curve. |
T228 |
22466-22621 |
Sentence |
denotes |
Distances are given in Å. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) |
T229 |
22622-22698 |
Sentence |
denotes |
Fig. 4 Modeling results in the SAM binding pocket of SARS-CoV nsp14 (PDB ID: |
T230 |
22699-22864 |
Sentence |
denotes |
5C8T, resolution 3.2 Å). (A) Contribution of the nitrobenzenesulfonamide core of 13. (B) Contribution of the 2′O linked adenosine of all dinucleosides, including 13. |
T231 |
22865-23185 |
Sentence |
denotes |
Hydrogen bonds (yellow), halogen bond (green) and π-π stacking interaction (cyan) are represented. (Atoms not involved in protein-ligand interaction are not represented for clarity purpose). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) |